1700040I university of texas medical branch; to 09 task B06 FY2018 obra--13 base task order funding; biod can 8470038; $3,465,763

Ended Awarded Last action

Contract number
75N93018F00009
Awardee
Awarding agency
Obligated
$2,920,417

Award facts

Opportunity
  • NIHAI2016059 Solicitation number
Contract value 100% obligated
$2,920,416.99 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Galveston, TX 77555, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00004 · To DE-obligate FY 2018 funds in the amount of $545,346.01. -$545,346
Other Administrative Action P00003 · To issue a no additional cost extension to the base period $0
Other Administrative Action P00002 · To include sars-COV-2 as one of the tested viruses as reflected in attachment 1 of this task order contract. All other terms and conditions of this contract… $0
Other Administrative Action P00001 $0
Original award $3,465,763

About this award

Written by GovTribe AI ·

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Texas Medical Branch at Galveston (UTMB). The $3,465,763 cost-reimbursement task order is part of a larger indefinite delivery contract (IDC) valued at $146.3 million that UTMB holds with NIAID to provide preclinical services for infectious disease research. Under this task order, UTMB will conduct studies related to the development of medical countermeasures against infectious diseases. The contract does not have a small business set-aside designation. UTMB, a state government-owned academic medical center, has extensive experience supporting federal agencies in biomedical research and healthcare through contracts and grants. As a prime contractor, UTMB leverages its specialized biosafety laboratories and expertise in areas such as emerging infectious diseases, vaccine development, and chemical/biological defense.

Quick answers

Who was awarded contract 75N93018F00009?

75N93018F00009 was awarded to University Of Texas Medical Branch At Galveston by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 11, 2018.

How much is contract 75N93018F00009 worth?

The government has obligated $2,920,417 on 75N93018F00009.

Is contract 75N93018F00009 an order under another contract?

Yes. 75N93018F00009 is a delivery order under HHSN272201700040I, an indefinite delivery contract, on NIAID Preclinical Models of Infectious Diseases 2017-2024.

Was contract 75N93018F00009 competed?

The extent of competition for 75N93018F00009 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login